The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
Renna Molajoni
E
E
Divisione Trapianti d'Organo, Cattedra di Patologia Chirurgica II, Università di Roma, La Sapienza, Italy.
Cinti
P
P
Evangelista
B
B
Poli
L
L
Cocciolo
P
P
Berloco
P
P
Cortesini
R
R
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D010835:Phytohemagglutinins; D011237:Predictive Value of Tests; D012307:Risk Factors; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D010835:Phytohemagglutinins; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone